C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma
Status:
Completed
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
Positron emission tomography using carbon-11 acetate (AC-PET) may help find local or distant
metastases from prostate cancer. This clinical trial is studying how this imaging test may
help influence the choice and extent of initial treatments, and subsequent treatments.